chr2-84423583-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003849.4(SUCLG1):c.*163T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.896 in 710,918 control chromosomes in the GnomAD database, including 290,493 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.81 ( 52676 hom., cov: 33)
Exomes 𝑓: 0.92 ( 237817 hom. )
Consequence
SUCLG1
NM_003849.4 3_prime_UTR
NM_003849.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.443
Genes affected
SUCLG1 (HGNC:11449): (succinate-CoA ligase GDP/ADP-forming subunit alpha) This gene encodes the alpha subunit of the heterodimeric enzyme succinate coenzyme A ligase. This enzyme is targeted to the mitochondria and catalyzes the conversion of succinyl CoA and ADP or GDP to succinate and ATP or GTP. Mutations in this gene are the cause of the metabolic disorder fatal infantile lactic acidosis and mitochondrial DNA depletion. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-84423583-A-G is Benign according to our data. Variant chr2-84423583-A-G is described in ClinVar as [Benign]. Clinvar id is 337149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.927 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUCLG1 | NM_003849.4 | c.*163T>C | 3_prime_UTR_variant | 9/9 | ENST00000393868.7 | NP_003840.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUCLG1 | ENST00000393868.7 | c.*163T>C | 3_prime_UTR_variant | 9/9 | 1 | NM_003849.4 | ENSP00000377446 | P1 | ||
SUCLG1 | ENST00000484365.1 | n.1712T>C | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
SUCLG1 | ENST00000491123.5 | n.1050T>C | non_coding_transcript_exon_variant | 4/4 | 3 | |||||
SUCLG1 | ENST00000651342.1 | c.*644T>C | 3_prime_UTR_variant, NMD_transcript_variant | 10/10 | ENSP00000498471 |
Frequencies
GnomAD3 genomes AF: 0.810 AC: 123161AN: 152112Hom.: 52670 Cov.: 33
GnomAD3 genomes
AF:
AC:
123161
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.920 AC: 513825AN: 558688Hom.: 237817 Cov.: 6 AF XY: 0.921 AC XY: 275883AN XY: 299434
GnomAD4 exome
AF:
AC:
513825
AN:
558688
Hom.:
Cov.:
6
AF XY:
AC XY:
275883
AN XY:
299434
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.809 AC: 123200AN: 152230Hom.: 52676 Cov.: 33 AF XY: 0.814 AC XY: 60581AN XY: 74448
GnomAD4 genome
AF:
AC:
123200
AN:
152230
Hom.:
Cov.:
33
AF XY:
AC XY:
60581
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3087
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Mitochondrial DNA depletion syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Mitochondrial DNA depletion syndrome 9 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at